Regenerative Medicine Market Dynamics 2019: Global Size, Growth, Share & Industry Analysis 2026
Global Regenerative Medicine Market by top players, type and application, with sales market share, growth & Industry Dynamics 2025
India – September 9, 2019 /MarketersMedia/ —
The global regenerative medicine market is likely to expand considerably in the coming years due to growing applications in the treatment of chronic diseases. According to a report published by Fortune Business Insights, titled “Regenerative Medicine: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 23,841.5 Mn in 2018. Fortune Business Insights states that the market will reach US$ 151,949.5 Mn by the end of 2026, thereby exhibiting a CAGR of 26.1%.
Recent developments in treatment of acute and chronic diseases can be attributed to advances in regenerative medicines. Regenerative medicine mainly focuses on identifying the root cause of the disease and aims at locating, repairing, and regenerating the non-functioning body cells. As most of the chronic and acute diseases are inclined towards the elderly and geriatric population, the growing geriatric population serves regenerative medicine market growth in the coming years.
Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/regenerative-medicine-market-100970
Company profiled in Regenerative Medicine Market report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
-Integra LifeSciences Corporation
-CELGENE CORPORATION
-Medtronic
-American CryoStem Corporation
-Tissue Regenix
-Avita Medical
-Osiris Therapeutics, Inc.
-Wright Medical Group N.V.
-Smith & Nephew
-Integra LifeSciences Corporation
Novartis Receives EU Approval for Luxturna
The severity of chronic diseases has led to the demand for efficient medicines. The ability of regenerative medicine to treat severe life-threatening diseases in an efficient manner has created a huge demand for the products across the world. Increasing drug approvals have contributed to the rising uptake for Regenerative Medicine Market Share. In 2018, Novartis received usage approval from the European Union for its latest regenerative medicine ‘Luxturna’.
The drug was used to treat and restore sight for people with vision impairment. Luxturna was widely useful in treatment of rare retinal diseases. Fortune Business Insights states that the approval for Luxturna will contribute to the regenerative medicine market growth in the forthcoming years.
Get Sample PDF Brochure@ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/regenerative-medicine-market-100970
Segmentations of Regenerative Medicine Market Dynamics:
By Product
· Cell Therapy
· Gene Therapy
· Tissue Engineering
· Platelet Rich Plasma
By Application
· Orthopedics
· Wound Care
· Oncology
· Others
By Distribution Channel
· Hospitals
· Clinics
· Others
By Geography
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Integra LifeSciences’ Latest Product Offering Will Favor Regenerative Medicine Market Growth
The advancements in regenerative medicine have fueled their demand across the world. Increasing product launches have contributed to the rising uptake of regenerative medicine across the world. In 2017, Integra LifeSciences announced the launch of Integra Dermal Regeneration Template Single Layer ‘Thin’. The product was aimed at repairing dermal defects in a one-step procedure. The medicine will also aid in reducing hospital stays.
Some of the leading companies that are operating in the Regenerative Medicine Market are Integra LifeSciences Corporation, CELGENE CORPORATION, Medtronic, American CryoStem Corporation, Tissue Regenix, Avita Medical, Osiris Therapeutics, Inc., Wright Medical Group N.V., Smith & Nephew, and Integra LifeSciences Corporation.
Buy Now@ https://www.fortunebusinessinsights.com/checkout-page/100970
TABLE OF CONTENT on Regenerative Medicine Market:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Regenerative Medicine Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence and incidence of diabetes, by key countries
4.2. Advancements in insulin delivery devices
4.3. Pricing Analysis, by key players
4.4. Technological Advancements
4.5. Key mergers & acquisitions, by key players
More Trending Topics from Future Business Insights-
The Psoriatic Arthritis Treatment Market Share will Touch US$ 12,175.2 Million by 2026
The Telehealth Market is Anticipated to Touch US$ 266.8 Billion by 2026
Contact Info:
Name: Mr. Ashwin Arora
Email: Send Email
Organization: Fortune Business Insights Pvt. Ltd.
Website: https://www.fortunebusinessinsights.com/
Source: MarketersMedia
Release ID: 88916747
Copyright © 1999-2013 SproutNews.com
